
Clinical trials have served as valuable tools for evaluating new therapeutic strategies in the treatment of zzso Traditionally, new pharmaceuticals and procedures have been zzso on the basis of effectiveness, zzso and zzso Recently, economic concerns have become increasingly important when considering treatment strategies for cancer zzso The national emphasis on assessing the costs of health care has focused primarily on the zzso of resource zzso Policy makers are exhibiting greater interest in economic data to supplement clinical data of new procedures and pharmaceutical agents before the approval and widespread application of such zzso Clinical trials have increasingly become viewed as a proper setting for such economic zzso In this paper, we review operational details for carrying out economic analyses of clinical trials being conducted in the cancer cooperative group zzso 

